Supplementary Figure 2. Whole genome sequencing results of SARS-CoV-2 positive cases from the vaccine effectiveness study (N=39) and from GISAID data for Azerbaijan (N=2) by week during the study period, May 17 – November 30, 2021 (N=41).*